J.P. Morgan Ventures CORP Insider Trading $CYTO CYTOGEN CORP
FREE EMAIL WATCHDOG
Get free email notifications about insider trading for J.P. Morgan Ventures CORP.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insider Transactions | Monthly Overview
Get the latest insider transactions of J.P. Morgan Ventures CORP. J.P. Morgan Ventures CORP is 10% Owner in ALPHARMA INC ($ALO) and 10% Owner in CANDELA CORP /DE/ ($CLZR) and 10% Owner in CYTOGEN CORP ($CYTO).
J.P. Morgan Ventures CORP in CYTOGEN CORP
Trading Symbol: CYTOIndustry: PHARMACEUTICAL PREPARATIONS [2834]
Position of J.P. Morgan Ventures CORP: 10% Owner
Holdings: 0 shares
Latest Transaction: May 12 2008
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD
Latest Insider Trading Transactions of J.P. Morgan Ventures CORP in CYTOGEN CORP
1 Week | 2 Weeks | 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | |
---|---|---|---|---|---|---|---|
No. of Purchases | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Value of Purchases ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
No. of Sales | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Value of Sales ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Sentiment: All, ALO, CLZR, CYTO
Page: 1
Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
---|---|---|---|---|---|---|---|---|---|---|---|
May 12 2008 | CYTO | CYTOGEN CORP | J.P. Morgan Ventures CORP | 10% Owner | Option Exercise | J | 2.23 | 1,000,000 | 2,231,000 | 0 | |
May 12 2008 | CYTO | CYTOGEN CORP | J.P. Morgan Ventures CORP | 10% Owner | Sell | J | 0.62 | 4,919,000 | 3,049,780 | 0 | 4.9 M to 0 (-100.00 %) |
Dec 19 2007 | CYTO | CYTOGEN CORP | J.P. Morgan Ventures CORP | 10% Owner | Buy | P | 0.50 | 8,000 | 4,018 | 4,919,000 | 4.9 M to 4.9 M (+0.16 %) |
Dec 19 2007 | CYTO | CYTOGEN CORP | J.P. Morgan Ventures CORP | 10% Owner | Buy | P | 0.50 | 46,000 | 23,023 | 4,911,000 | 4.9 M to 4.9 M (+0.95 %) |
Dec 14 2007 | CYTO | CYTOGEN CORP | J.P. Morgan Ventures CORP | 10% Owner | Buy | P | 0.51 | 33,000 | 16,837 | 4,865,000 | 4.8 M to 4.9 M (+0.68 %) |
Dec 14 2007 | CYTO | CYTOGEN CORP | J.P. Morgan Ventures CORP | 10% Owner | Buy | P | 0.54 | 51,000 | 27,535 | 4,832,000 | 4.8 M to 4.8 M (+1.07 %) |
Dec 14 2007 | CYTO | CYTOGEN CORP | J.P. Morgan Ventures CORP | 10% Owner | Buy | P | 0.55 | 57,000 | 31,253 | 4,781,000 | 4.7 M to 4.8 M (+1.21 %) |
Dec 06 2007 | CYTO | CYTOGEN CORP | J.P. Morgan Ventures CORP | 10% Owner | Buy | P | 0.64 | 1,000 | 645 | 4,724,000 | 4.7 M to 4.7 M (+0.02 %) |
Dec 06 2007 | CYTO | CYTOGEN CORP | J.P. Morgan Ventures CORP | 10% Owner | Buy | P | 0.59 | 86,000 | 50,757 | 4,723,000 | 4.6 M to 4.7 M (+1.85 %) |
Dec 03 2007 | CYTO | CYTOGEN CORP | J.P. Morgan Ventures CORP | 10% Owner | Buy | P | 0.59 | 7,000 | 4,150 | 4,637,000 | 4.6 M to 4.6 M (+0.15 %) |
Nov 28 2007 | CYTO | CYTOGEN CORP | J.P. Morgan Ventures CORP | 10% Owner | Buy | P | 0.60 | 76,100 | 45,637 | 4,630,000 | 4.6 M to 4.6 M (+1.67 %) |
Nov 28 2007 | CYTO | CYTOGEN CORP | J.P. Morgan Ventures CORP | 10% Owner | Buy | P | 0.59 | 93,900 | 55,636 | 4,553,900 | 4.5 M to 4.6 M (+2.11 %) |
Nov 28 2007 | CYTO | CYTOGEN CORP | J.P. Morgan Ventures CORP | 10% Owner | Buy | P | 0.56 | 30,000 | 16,797 | 4,460,000 | 4.4 M to 4.5 M (+0.68 %) |
Nov 28 2007 | CYTO | CYTOGEN CORP | J.P. Morgan Ventures CORP | 10% Owner | Buy | P | 0.59 | 100,000 | 59,000 | 4,430,000 | 4.3 M to 4.4 M (+2.31 %) |
Nov 28 2007 | CYTO | CYTOGEN CORP | J.P. Morgan Ventures CORP | 10% Owner | Buy | P | 0.59 | 29,000 | 17,110 | 4,330,000 | 4.3 M to 4.3 M (+0.67 %) |
Nov 20 2007 | CYTO | CYTOGEN CORP | J.P. Morgan Ventures CORP | 10% Owner | Buy | P | 0.62 | 23,000 | 14,274 | 4,301,000 | 4.3 M to 4.3 M (+0.54 %) |
Nov 16 2007 | CYTO | CYTOGEN CORP | J.P. Morgan Ventures CORP | 10% Owner | Buy | P | 0.60 | 58,000 | 34,759 | 4,278,000 | 4.2 M to 4.3 M (+1.37 %) |
Nov 16 2007 | CYTO | CYTOGEN CORP | J.P. Morgan Ventures CORP | 10% Owner | Buy | P | 0.61 | 250,000 | 152,500 | 4,220,000 | 4 M to 4.2 M (+6.30 %) |
Nov 16 2007 | CYTO | CYTOGEN CORP | J.P. Morgan Ventures CORP | 10% Owner | Buy | P | 0.60 | 368,000 | 220,726 | 3,970,000 | 3.6 M to 4 M (+10.22 %) |
Page: 1